Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 92

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 92
---
 and capital expenditure requirements; |

| ● | our ability to generate revenue and profit margin under our anticipated contracts which is subject to certain risks; |

| ● | difficulties in our and our partners’ ability to recruit and retain qualified physicians and other healthcare professionals, and enforce our non-compete agreements with our physicians; |

<div align='center'>56</div>

| ● | our ability to restructure our operations to comply with future changes in government regulation; |

| ● | our ability to address any competing technological and market developments that impact our Gelrin hydrogel platform and any future product candidates or their prospective usage by medical professionals; |

| ● | our ability to negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and perform our obligations under such collaborations; |

| ● | our ability to maintain, protect and expand our portfolio of intellectual property rights, including patents, patent applications, trade secrets and know-how; |
| ● | our expectations regarding having our Ordinary Shares listed on The Nasdaq Capital Market;                                                                     |

| ● | our anticipated use of the net proceeds from this offering; and |

| ● | statements as to the impact of the political and security situation in Israel on our business, including due to war or conflicts between Israel, Hamas, Hezbollah, and on other fronts from various extremist groups in the region, such as the Houthis in Yemen and various rebel militia groups in Syria and Iraq. |

Forward-looking statements
are based on our management’s current expectations, estimates, forecasts and projections about our business and the industry in
which we operate and our management’s beliefs and assumptions, and are not guarantees of future performance or development and involve
known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking
statements in this prospectus may turn out to be inaccurate. Important factors that may cause actual results to differ materially from
current expectations include, among other things, those listed under “Risk Factors” and elsewhere in this prospectus. Potential
investors are urged to consider these factors carefully in evaluating the forward-looking statements.

The forward-looking statements
included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected
in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise